Literature DB >> 24900340

N-Methylated sst2 Selective Somatostatin Cyclic Peptide Analogue as a Potent Candidate for Treating Neurogenic Inflammation.

Jayanta Chatterjee1, Burkhardt Laufer1, Johannes G Beck1, Zsuzsanna Helyes2, Erika Pintér2, János Szolcsányi2, Aniko Horvath3, Jozsef Mandl3, Jean C Reubi4, György Kéri3, Horst Kessler1.   

Abstract

A focused multiply N-methylated library of a cyclic hexapeptidic somatostatin analogue: MK678 cyclo(-MeAYwKVF-) was generated, which resulted in the unexpected observation of an efficacious tetra-N-methylated analogue, cyclo(-MeAYMewMeKVMeF-) with a potent inhibitory action on sensory neuropeptide release in vitro and on acute neurogenic inflammatory response in vivo. The analogue shows selectivity toward somatostatin receptor subtype 2 (sst2). Extensive 2D NMR spectroscopy and molecular dynamics simulation revealed the solution conformation of the analogue, which can be adopted as a lead for the further structure-activity relationship studies targeting neurogenic inflammation.

Entities:  

Keywords:  N-methylated peptide; Somatostatin; cyclic peptide; multiple N-methylation; neurogenic inflammation; sst

Year:  2011        PMID: 24900340      PMCID: PMC4018149          DOI: 10.1021/ml200032v

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  19 in total

1.  Investigation of the role of TRPV1 receptors in acute and chronic nociceptive processes using gene-deficient mice.

Authors:  Kata Bölcskei; Zsuzsanna Helyes; Árpád Szabó; Katalin Sándor; Krisztián Elekes; József Németh; Róbert Almási; Erika Pintér; Gábor Pethő; János Szolcsányi
Journal:  Pain       Date:  2005-10       Impact factor: 6.961

2.  Inhibition by nociceptin of neurogenic inflammation and the release of SP and CGRP from sensory nerve terminals.

Authors:  Z Helyes; J Németh; E Pintér; J Szolcsányi
Journal:  Br J Pharmacol       Date:  1997-06       Impact factor: 8.739

Review 3.  Neuropeptides in the skin: interactions between the neuroendocrine and the skin immune systems.

Authors:  T Scholzen; C A Armstrong; N W Bunnett; T A Luger; J E Olerud; J C Ansel
Journal:  Exp Dermatol       Date:  1998 Apr-Jun       Impact factor: 3.960

4.  Optimized selective N-methylation of peptides on solid support.

Authors:  Eric Biron; Jayanta Chatterjee; Horst Kessler
Journal:  J Pept Sci       Date:  2006-03       Impact factor: 1.905

5.  A potent cyclic hexapeptide analogue of somatostatin.

Authors:  D F Veber; R M Freidlinger; D S Perlow; W J Paleveda; F W Holly; R G Strachan; R F Nutt; B H Arison; C Homnick; W C Randall; M S Glitzer; R Saperstein; R Hirschmann
Journal:  Nature       Date:  1981-07-02       Impact factor: 49.962

6.  Release of somatostatin and its role in the mediation of the anti-inflammatory effect induced by antidromic stimulation of sensory fibres of rat sciatic nerve.

Authors:  J Szolcsányi; Z Helyes; G Oroszi; J Németh; E Pintér
Journal:  Br J Pharmacol       Date:  1998-03       Impact factor: 8.739

7.  A super active cyclic hexapeptide analog of somatostatin.

Authors:  D F Veber; R Saperstein; R F Nutt; R M Freidinger; S F Brady; P Curley; D S Perlow; W J Paleveda; C D Colton; A G Zacchei
Journal:  Life Sci       Date:  1984-04-02       Impact factor: 5.037

Review 8.  Tachykinins and calcitonin gene-related peptide (CGRP) as co-transmitters released from peripheral endings of sensory nerves.

Authors:  C A Maggi
Journal:  Prog Neurobiol       Date:  1995-01       Impact factor: 11.685

9.  N-methylation of peptides: a new perspective in medicinal chemistry.

Authors:  Jayanta Chatterjee; Chaim Gilon; Amnon Hoffman; Horst Kessler
Journal:  Acc Chem Res       Date:  2008-07-18       Impact factor: 22.384

Review 10.  Molecular properties of somatostatin receptors.

Authors:  T Reisine; G I Bell
Journal:  Neuroscience       Date:  1995-08       Impact factor: 3.590

View more
  1 in total

1.  Synthesis of N-methylated cyclic peptides.

Authors:  Jayanta Chatterjee; Burkhardt Laufer; Horst Kessler
Journal:  Nat Protoc       Date:  2012-02-09       Impact factor: 13.491

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.